Umlaut.bio

About Umlaut.bio

Umlaut.bio is a pioneering biotechnology company focused on decoding RNA modifications and developing first-in-biology therapeutic molecules that modify tRNA to target cancer and inflammatory diseases. The company investigates RNA modification pathways to influence signaling and cell growth, aiming to treat cancers and autoimmune conditions. Based in Heidelberg, Germany, Umlaut.bio emphasizes targeted small molecules that inhibit key steps in tRNA modification to address diseases beyond traditional chemotherapy approaches.